Peptide Research

Clinical Trials Clinical Studies Clinical Evidence Clinical Applications

FDA Faces Choice on Allowing Six Experimental Peptides for Compounding

A federal decision could shift many users from unregulated overseas suppliers to licensed pharmacies and force a plan for coordinated research and safety oversight

8 ARTICLES

2mo ago

FDA Advisory Panel Narrowly Backs Compounding of Six Unapproved Peptides

29 ARTICLES

2mo ago

FDA Advisers Recommend BPC-157 for Pharmacy Compounding

9 ARTICLES

5mo ago

HHS Push to Ease Peptide Curbs Spurs FDA Review and Investor Bets